
news
Alembic Pharmaceuticals announces USFDA Final Approval for Nelarabine Injection 5v5f5l
2nd August 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug istration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nelarabine Injection, 250 […]